{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:30:55Z","timestamp":1791167455380,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T00:00:00Z","timestamp":1241654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1038\/nrcardio.2009.57","type":"journal-article","created":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T11:47:30Z","timestamp":1241696850000},"page":"410-417","source":"Crossref","is-referenced-by-count":247,"title":["Role for TNF in atherosclerosis? Lessons from autoimmune disease"],"prefix":"10.1038","volume":"6","author":[{"given":"Gayle E.","family":"McKellar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"McCarey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain B.","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,7]]},"reference":[{"key":"BFnrcardio200957_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB McInnes","year":"2007","unstructured":"McInnes, I. B. & Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7, 429\u2013442 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrcardio200957_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","volume":"14","author":"M Feldmann","year":"1996","unstructured":"Feldmann, M., Brennan, F. M. & Maini, R. N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14, 397\u2013440 (1996).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrcardio200957_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1042\/CS20080196","volume":"116","author":"H Zhang","year":"2009","unstructured":"Zhang, H.  et al. Role of TNF-alpha in vascular dysfunction. Clin. Sci. (Lond.). 116, 219\u2013230 (2009).","journal-title":"Clin. Sci. (Lond.)."},{"key":"BFnrcardio200957_CR4","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1136\/ard.2006.066605","volume":"66","author":"J Grisar","year":"2007","unstructured":"Grisar, J.  et al. Endothelial progenitor cells in active rheumatoid arthritis: effects of tumournecrosis factor and glucocorticoid therapy. Ann. Rheum. Dis. 66, 1284\u20131288 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrcardio200957_CR5","doi-asserted-by":"publisher","first-page":"H1817","DOI":"10.1152\/ajpheart.00472.2008","volume":"295","author":"K Quinn","year":"2008","unstructured":"Quinn, K., Henriques, M., Parker, T., Slutsky, A. S. & Zhang, H. Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases. Am. J. Physiol. Heart Circ. Physiol. 295, H1817\u2013H1824 (2008).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio200957_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cca.2007.11.025","volume":"389","author":"SP Zhao","year":"2008","unstructured":"Zhao, S. P. & Dong, S. Z. Effect of tumor necrosis factor alpha on cholesterol efflux in adipocytes. Clin. Chim. Acta 389, 67\u201371 (2008).","journal-title":"Clin. Chim. Acta"},{"key":"BFnrcardio200957_CR7","doi-asserted-by":"publisher","first-page":"35361","DOI":"10.1074\/jbc.M504611200","volume":"280","author":"MT Nguyen","year":"2005","unstructured":"Nguyen, M. T.  et al. JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J. Biol. Chem. 280, 35361\u201335371 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrcardio200957_CR8","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/art.10089","volume":"46","author":"S Van Doornum","year":"2002","unstructured":"Van Doornum, S., McColl, G. & Wicks, I. P. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum. 46, 862\u2013873 (2002).","journal-title":"Arthritis Rheum."},{"key":"BFnrcardio200957_CR9","first-page":"2099","volume":"29","author":"H Capell","year":"2002","unstructured":"Capell, H., McCarey, D., Madhok, R. & Hampson, R. \u201c5D\u201d Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy. J. Rheumatol. 29, 2099\u20132105 (2002).","journal-title":"J. Rheumatol."},{"key":"BFnrcardio200957_CR10","first-page":"445","volume":"24","author":"S Wallberg-Jonsson","year":"1997","unstructured":"Wallberg-Jonsson, S., Ohman, M. L. & Dahlqvist, S. R. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J. Rheumatol. 24, 445\u2013451 (1997).","journal-title":"J. Rheumatol."},{"key":"BFnrcardio200957_CR11","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","volume":"44","author":"ID del Rinc\u00f3n","year":"2001","unstructured":"del Rinc\u00f3n, I. D., Williams, K., Stern, M. P., Freeman, G. L. & Escalante, A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 44, 2737\u20132745 (2001).","journal-title":"Arthritis Rheum."},{"key":"BFnrcardio200957_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/art.22482","volume":"57","author":"MA Gonzalez-Gay","year":"2007","unstructured":"Gonzalez-Gay, M. A.  et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum. 57, 125\u2013132 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrcardio200957_CR13","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","volume":"108","author":"N Sattar","year":"2003","unstructured":"Sattar, N., McCarey, D. W., Capell, H. & McInnes, I. B. Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108, 2957\u20132963 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio200957_CR14","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/art.24092","volume":"59","author":"JA Avi\u00f1a-Zubieta","year":"2008","unstructured":"Avi\u00f1a-Zubieta, J. A.  et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 59, 1690\u20131697 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrcardio200957_CR15","doi-asserted-by":"publisher","first-page":"R116","DOI":"10.1186\/ar2323","volume":"9","author":"S Hannawi","year":"2007","unstructured":"Hannawi, S., Haluska, B., Marwick, T. H. & Thomas, R. Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res. Ther. 9, R116 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrcardio200957_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/ar2471","volume":"10","author":"BH Hahn","year":"2008","unstructured":"Hahn, B. H., Grossman, J., Ansell, B. J., Skaggs, B. J. & McMahon, M. Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res. Ther. 10, 213 (2008).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrcardio200957_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","volume":"127","author":"X Cheng","year":"2008","unstructured":"Cheng, X.  et al. The Th17\/Treg imbalance in patients with acute coronary syndrome. Clin. Immunol. 127, 89\u201397 (2008).","journal-title":"Clin. Immunol."},{"key":"BFnrcardio200957_CR18","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1161\/01.CIR.100.21.2124","volume":"100","author":"V Pasceri","year":"1999","unstructured":"Pasceri, V. & Yeh, E. T. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 100, 2124\u20132126 (1999).","journal-title":"Circulation"},{"key":"BFnrcardio200957_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0092-8674(00)81109-5","volume":"85","author":"M Feldmann","year":"1996","unstructured":"Feldmann, M., Brennan, F. M. & Maini, R. N. Rheumatoid arthritis. Cell 85, 307\u2013310 (1996).","journal-title":"Cell"},{"key":"BFnrcardio200957_CR20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0140-6736(89)90430-3","volume":"2","author":"FM Brennan","year":"1989","unstructured":"Brennan, F. M., Chantry, D., Jackson, A., Maini, R. & Feldmann, M. Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2, 244\u2013247 (1989).","journal-title":"Lancet"},{"key":"BFnrcardio200957_CR21","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","volume":"10","author":"J Keffer","year":"1991","unstructured":"Keffer, J.  et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10, 4025\u20134031 (1991).","journal-title":"EMBO J."},{"key":"BFnrcardio200957_CR22","doi-asserted-by":"publisher","first-page":"9784","DOI":"10.1073\/pnas.89.20.9784","volume":"89","author":"RO Williams","year":"1992","unstructured":"Williams, R. O., Feldmann, M. & Maini, R. N. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl Acad. Sci. USA 89, 9784\u20139788 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrcardio200957_CR23","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","volume":"354","author":"R Maini","year":"1999","unstructured":"Maini, R.  et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet 354, 1932\u20131939 (1999).","journal-title":"Lancet"},{"key":"BFnrcardio200957_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","volume":"19","author":"M Feldmann","year":"2001","unstructured":"Feldmann, M. & Maini, R. N. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol. 19, 163\u2013196 (2001).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrcardio200957_CR25","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1056\/NEJM200011303432201","volume":"343","author":"JM Bathon","year":"2000","unstructured":"Bathon, J. M.  et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N. Engl. J. Med. 343, 1586\u20131593 (2000).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio200957_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.10697","volume":"48","author":"ME Weinblatt","year":"2003","unstructured":"Weinblatt, M. E.  et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum. 48, 35\u201345 (2003).","journal-title":"Arthritis Rheum."},{"key":"BFnrcardio200957_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0021-9150(03)00281-8","volume":"170","author":"S H\u00e4nsel","year":"2003","unstructured":"H\u00e4nsel, S., L\u00e4ssig, G., Pistrosch, F. & Passauer, J. Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity. Atherosclerosis 170, 177\u2013180 (2003).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio200957_CR28","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1161\/01.CIR.0000124720.18538.DD","volume":"109","author":"AD Booth","year":"2004","unstructured":"Booth, A. D.  et al. Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation. Circulation 109, 1718\u20131723 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio200957_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/art.22530","volume":"57","author":"C Gonzalez-Juanatey","year":"2007","unstructured":"Gonzalez-Juanatey, C.  et al. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum. 57, 287\u2013293 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrcardio200957_CR30","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","volume":"106","author":"D H\u00fcrlimann","year":"2002","unstructured":"H\u00fcrlimann, D.  et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106, 2184\u20132187 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio200957_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2004.04.031","volume":"177","author":"C Irace","year":"2004","unstructured":"Irace, C.  et al. Effect of anti TNFalpha therapy on arterial diameter and wall shear stress and HDL cholesterol. Atherosclerosis 177, 113\u2013118 (2004).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio200957_CR32","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1161\/01.HYP.37.5.1236","volume":"37","author":"S Laurent","year":"2001","unstructured":"Laurent, S.  et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37, 1236\u20131241 (2001).","journal-title":"Hypertension"},{"key":"BFnrcardio200957_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1161\/hq0102.101770","volume":"22","author":"IB Wilkinson","year":"2002","unstructured":"Wilkinson, I. B.  et al. Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler. Thromb. Vasc. Biol. 22, 147\u2013152 (2002).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio200957_CR34","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/01.CIR.0000105767.94169.E3","volume":"109","author":"T Weber","year":"2004","unstructured":"Weber, T.  et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 109, 184\u2013189 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio200957_CR35","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.105.601641","volume":"114","author":"KM M\u00e4ki-Pet\u00e4j\u00e4","year":"2006","unstructured":"M\u00e4ki-Pet\u00e4j\u00e4, K. M.  et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 114, 1185\u20131192 (2006).","journal-title":"Circulation"},{"key":"BFnrcardio200957_CR36","first-page":"2388","volume":"34","author":"I Avalos","year":"2007","unstructured":"Avalos, I.  et al. Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis. J. Rheumatol. 34, 2388\u20132394 (2007).","journal-title":"J. Rheumatol."},{"key":"BFnrcardio200957_CR37","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1093\/rheumatology\/kei033","volume":"44","author":"S Van Doornum","year":"2005","unstructured":"Van Doornum, S., McColl, G. & Wicks, I. P. Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. Rheumatology (Oxford) 44, 1428\u20131432 (2005).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrcardio200957_CR38","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1136\/ard.2003.018333","volume":"63","author":"S Van Doornum","year":"2004","unstructured":"Van Doornum, S., McColl, G. & Wicks, I. P. Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. Ann. Rheum. Dis. 63, 1571\u20131575 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrcardio200957_CR39","first-page":"2597","volume":"28","author":"SW Jonsson","year":"2001","unstructured":"Jonsson, S. W.  et al. Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J. Rheumatol. 28, 2597\u20132602 (2001).","journal-title":"J. Rheumatol."},{"key":"BFnrcardio200957_CR40","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/art.22884","volume":"57","author":"C Gonzalez-Juanatey","year":"2007","unstructured":"Gonzalez-Juanatey, C.  et al. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum. 57, 1074\u20131780 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrcardio200957_CR41","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/art.21707","volume":"55","author":"C Gonzalez-Juanatey","year":"2006","unstructured":"Gonzalez-Juanatey, C., Llorca, J., Garcia-Porrua, C., Martin, J. & Gonzalez-Gay, M. A. Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis. Arthritis Rheum. 55, 150\u2013153 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrcardio200957_CR42","first-page":"1111","volume-title":"Rheumatology (Oxford)","author":"F Del Porto","year":"2007","unstructured":"Del Porto, F.  et al. Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima\u2013media thickness in patients with active rheumatoid arthritis. Rheumatology (Oxford) 46, 1111\u20131115 (2007)."},{"key":"BFnrcardio200957_CR43","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1172\/JCI117936","volume":"95","author":"GS Hotamisligil","year":"1995","unstructured":"Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L. & Spiegelman, B. M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95, 2409\u20132415 (1995).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio200957_CR44","first-page":"2907","volume":"83","author":"P Dandona","year":"1998","unstructured":"Dandona, P.  et al. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J. Clin. Endocrinol. Metab. 83, 2907\u20132910 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrcardio200957_CR45","first-page":"373","volume":"24","author":"MA Gonzalez-Gay","year":"2006","unstructured":"Gonzalez-Gay, M. A.  et al. Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 24, 373\u2013379 (2006).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrcardio200957_CR46","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1365-2362.2004.01390.x","volume":"34","author":"B Yazdani-Biuki","year":"2004","unstructured":"Yazdani-Biuki, B.  et al. Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-alpha antibody infliximab. Eur. J. Clin. Invest. 34, 641\u2013642 (2004).","journal-title":"Eur. J. Clin. Invest."},{"key":"BFnrcardio200957_CR47","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1136\/ard.2004.026534","volume":"64","author":"DN Kiortsis","year":"2005","unstructured":"Kiortsis, D. N., Mavridis, A. K., Vasakos, S., Nikas, S. N. & Drosos, A. A. Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann. Rheum. Dis. 64, 765\u2013766 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrcardio200957_CR48","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1093\/eurheartj\/ehm115","volume":"28","author":"N Sarwar","year":"2007","unstructured":"Sarwar, N., Sattar, N., Gudnason, V. & Danesh, J. Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies. Eur. Heart J. 28, 2491\u20132497 (2007).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio200957_CR49","doi-asserted-by":"crossref","unstructured":"British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, Stroke Association. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 91 (Suppl. 5), v1\u2013v52 (2005).","DOI":"10.1136\/hrt.2005.079988"},{"key":"BFnrcardio200957_CR50","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cca.2005.08.010","volume":"365","author":"Y Allanore","year":"2006","unstructured":"Allanore, Y., Kahan, A., Sellam, J., Ekindjian, O. G. & Borderie, D. Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis. Clin. Chim. Acta 365, 143\u2013148 (2006).","journal-title":"Clin. Chim. Acta"},{"key":"BFnrcardio200957_CR51","first-page":"252","volume":"32","author":"M Vis","year":"2005","unstructured":"Vis, M.  et al. Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis. J. Rheumatol. 32, 252\u2013255 (2005).","journal-title":"J. Rheumatol."},{"key":"BFnrcardio200957_CR52","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/ard.2004.023119","volume":"64","author":"C Popa","year":"2005","unstructured":"Popa, C.  et al. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Ann. Rheum. Dis. 64, 303\u2013305 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrcardio200957_CR53","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/art.22447","volume":"56","author":"N Sattar","year":"2007","unstructured":"Sattar, N.  et al. Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: a double-blind, placebo-controlled study. Arthritis Rheum. 56, 831\u2013839 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrcardio200957_CR54","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/ard.2006.059691","volume":"66","author":"MJ Peters","year":"2007","unstructured":"Peters, M. J.  et al. Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis. Ann. Rheum. Dis. 66, 958\u2013961 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrcardio200957_CR55","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1136\/ard.2006.066191","volume":"66","author":"C Popa","year":"2007","unstructured":"Popa, C.  et al. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis. Ann. Rheum. Dis. 66, 1503\u20131507 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrcardio200957_CR56","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0021-9150(77)90197-6","volume":"28","author":"S Rossner","year":"1977","unstructured":"Rossner, S. & Lofmark, C. Dyslipoproteinaemia in patients with active, chronic polyarthritis. A study on serum lipoproteins and triglyceride clearance (intravenous fat tolerance test). Atherosclerosis 28, 41\u201352 (1977).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio200957_CR57","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1097\/01.CCM.0000171272.50888.AD","volume":"33","author":"CL Vermont","year":"2005","unstructured":"Vermont, C. L.  et al. Serum lipids and disease severity in children with severe meningococcal sepsis. Crit. Care Med. 33, 1610\u20131615 (2005).","journal-title":"Crit. Care Med."},{"key":"BFnrcardio200957_CR58","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00689971","volume":"30","author":"CG Alexopoulos","year":"1992","unstructured":"Alexopoulos, C. G., Pournaras, S., Vaslamatzis, M., Avgerinos, A. & Raptis, S. Changes in serum lipids and lipoproteins in cancer patients during chemotherapy. Cancer Chemother. Pharmacol. 30, 412\u2013416 (1992).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"BFnrcardio200957_CR59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0022-2143(98)90083-X","volume":"131","author":"S Akgun","year":"1998","unstructured":"Akgun, S., Ertel, N. H., Mosenthal, A. & Oser, W. Postsurgical reduction of serum lipoproteins: interleukin-6 and the acute-phase response. J. Lab. Clin. Med. 131, 103\u2013108 (1998).","journal-title":"J. Lab. Clin. Med."},{"key":"BFnrcardio200957_CR60","doi-asserted-by":"crossref","unstructured":"Popa, C.  et al. Anti-inflammatory therapy with TNF\u03b1 inhibitors improves HDL-cholesterol anti-oxidative capacity in rheumatoid arthritis patients. Ann. Rheum. Dis. doi:10.1136\/ard.2008.092171 (2008).","DOI":"10.1136\/ard.2008.092171"},{"key":"BFnrcardio200957_CR61","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1136\/ard.2008.091967","volume":"68","author":"SS Jick","year":"2008","unstructured":"Jick, S. S., Choi, H., Li, L., McInnes, I. B. & Sattar, N. Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis. Ann. Rheum. Dis. 68, 546\u2013551 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrcardio200957_CR62","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/art.23281","volume":"58","author":"J Listing","year":"2008","unstructured":"Listing, J.  et al. Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis? Arthritis Rheum. 58, 667\u2013677 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrcardio200957_CR63","first-page":"1213","volume":"32","author":"LT Jacobsson","year":"2005","unstructured":"Jacobsson, L. T.  et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J. Rheumatol. 32, 1213\u20131218 (2005).","journal-title":"J. Rheumatol."},{"key":"BFnrcardio200957_CR64","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1002\/art.22809","volume":"56","author":"WG Dixon","year":"2007","unstructured":"Dixon, W. G.  et al. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum. 56, 2905\u20132912 (2007).","journal-title":"Arthritis Rheum."},{"issue":"Suppl. II","key":"BFnrcardio200957_CR65","first-page":"109","volume":"65","author":"WG Dixon","year":"2006","unstructured":"Dixon, W. G.  et al. Rates of myocardial infarction and cerebrovascular accident are reduced in patients with rheumatoid arthritis treated with anti-TNF therapy compared to those treated with traditional DMARDS: results from the BSR biologics register. Ann. Rheum. Dis. 65 (Suppl. II), 109 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrcardio200957_CR66","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","volume":"91","author":"DL Mann","year":"2002","unstructured":"Mann, D. L. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ. Res. 91, 988\u2013998 (2002).","journal-title":"Circ. Res."},{"key":"BFnrcardio200957_CR67","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1056\/NEJM199007263230405","volume":"323","author":"B Levine","year":"1990","unstructured":"Levine, B., Kalman, J., Mayer, L., Fillit, H. M. & Packer, M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323, 236\u2013241 (1990).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio200957_CR68","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"ES Chung","year":"2003","unstructured":"Chung, E. S.  et al. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107, 3133\u20133140 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio200957_CR69","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","volume":"109","author":"DL Mann","year":"2004","unstructured":"Mann, D. L.  et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109, 1594\u20131602 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio200957_CR70","doi-asserted-by":"publisher","first-page":"807","DOI":"10.7326\/0003-4819-138-10-200305200-00008","volume":"138","author":"HJ Kwon","year":"2003","unstructured":"Kwon, H. J., Cot\u00e9, T. R., Cuffe, M. S., Kramer, J. M. & Braun, M. M. Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann. Intern. Med. 138, 807\u2013811 (2003).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio200957_CR71","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/art.20855","volume":"52","author":"PJ Nicola","year":"2005","unstructured":"Nicola, P. J.  et al. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum. 52, 412\u2013420 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrcardio200957_CR72","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","volume":"371","author":"JS Smolen","year":"2008","unstructured":"Smolen, J. S.  et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 371, 987\u2013997 (2008).","journal-title":"Lancet"},{"key":"BFnrcardio200957_CR73","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1136\/ard.2008.101964","volume":"68","author":"E Choy","year":"2009","unstructured":"Choy, E. & Sattar, N. Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Ann. Rheum. Dis. 68, 460\u2013469 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrcardio200957_CR74","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1002\/art.24308","volume":"59","author":"C Gonzalez-Juanatey","year":"2008","unstructured":"Gonzalez-Juanatey, C.  et al. Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy. Arthritis Rheum. 59, 1821\u20131824 (2008).","journal-title":"Arthritis Rheum."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2009.57.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2009.57","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrcardio.2009.57","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2009.57.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:44:47Z","timestamp":1684467887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2009.57"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,7]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["BFnrcardio200957"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2009.57","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,7]]}}}